An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry.
Publication
, Journal Article
Weiss, DJ; Filiano, A; Galipeau, J; Khoury, M; Krampera, M; Lalu, M; Blanc, KL; Nolta, J; Phinney, DG; Rocco, PRM; Shi, Y; Tarte, K ...
Published in: Cytotherapy
November 2022
Duke Scholars
Published In
Cytotherapy
DOI
EISSN
1477-2566
Publication Date
November 2022
Volume
24
Issue
11
Start / End Page
1071 / 1073
Location
England
Related Subject Headings
- Registries
- Mesenchymal Stem Cells
- Mesenchymal Stem Cell Transplantation
- Immunology
- Humans
- Genetic Therapy
- Clinical Trials as Topic
- COVID-19
- 3206 Medical biotechnology
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Weiss, D. J., Filiano, A., Galipeau, J., Khoury, M., Krampera, M., Lalu, M., … Martin, I. (2022). An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry. Cytotherapy, 24(11), 1071–1073. https://doi.org/10.1016/j.jcyt.2022.07.010
Weiss, Daniel J., Anthony Filiano, Jacques Galipeau, Maroun Khoury, Mauro Krampera, Manoj Lalu, Katarina Le Blanc, et al. “An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry.” Cytotherapy 24, no. 11 (November 2022): 1071–73. https://doi.org/10.1016/j.jcyt.2022.07.010.
Weiss DJ, Filiano A, Galipeau J, Khoury M, Krampera M, Lalu M, et al. An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry. Cytotherapy. 2022 Nov;24(11):1071–3.
Weiss, Daniel J., et al. “An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry.” Cytotherapy, vol. 24, no. 11, Nov. 2022, pp. 1071–73. Pubmed, doi:10.1016/j.jcyt.2022.07.010.
Weiss DJ, Filiano A, Galipeau J, Khoury M, Krampera M, Lalu M, Blanc KL, Nolta J, Phinney DG, Rocco PRM, Shi Y, Tarte K, Viswanathan S, Martin I. An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry. Cytotherapy. 2022 Nov;24(11):1071–1073.
Published In
Cytotherapy
DOI
EISSN
1477-2566
Publication Date
November 2022
Volume
24
Issue
11
Start / End Page
1071 / 1073
Location
England
Related Subject Headings
- Registries
- Mesenchymal Stem Cells
- Mesenchymal Stem Cell Transplantation
- Immunology
- Humans
- Genetic Therapy
- Clinical Trials as Topic
- COVID-19
- 3206 Medical biotechnology
- 3204 Immunology